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Background: The Fear of Pain Questionnaire-III (FPQ-III) is a widely used instrument to 
assess the fear of pain (FOP) in clinical and nonclinical samples. The FPQ-III has 30 items and 
is divided into three subscales: Severe Pain, Minor Pain and Medical Pain. Due to findings of 
poor fit of the original three-factor FPQ-III model, the Fear of Pain Questionnaire-Short Form 
(FPQ-SF) four-factor model has been suggested as an alternative. The FPQ-SF is a revised 
version of the FPQ-III, reduced to 20 items and subdivided into four subscales: Severe Pain, 
Minor Pain, Injection Pain and Dental Pain.
Aims and methods: The purpose of the study was to investigate the model fit, reliability and 
validity of the FPQ-III and the FPQ-SF in a Norwegian nonclinical sample, using confirmatory 
factor analysis (CFA). The second aim was to explore the model fit of the two scales in male 
and female subgroups separately, since previous studies have uncovered differences in how well 
the questionnaires measure FOP across sex; thus, the questionnaires might not be sex neutral. It 
has been argued that the FPQ-SF model is better because of the higher fit to the data across sex. 
To explore model fit across sex within the questionnaires, the model fit, validity and reliability 
were compared across sex using CFA.
Results: The results revealed that both models’ original factor structures had poor fit. However, 
the FPQ-SF had a better fit overall, compared to the FPQ-III. The model fit of the two models 
differed across sex, with better fit for males on the FPQ-III and for females on the FPQ-SF.
Conclusion: The FPQ-SF is a better questionnaire than the FPQ-III for measurement of FOP 
in Norwegian samples and across sex subgroups. However, the FPQ-III is a better questionnaire 
for males than for females, whereas the FPQ-SF is a better questionnaire for females than for 
males. The findings are discussed and directions for future investigations outlined.
Keywords: fear of pain, FPQ-III, FPQ-SF, confirmatory factor analysis, pain, sex
Introduction
Fear of pain (FOP) is associated with emotional reactions occurring in the anticipation 
of pain or during pain.1 FOP is related to increased pain perception2–4 and reduced 
capacity for pain inhibition,1 and is a central mechanism in several pain disorders.5,6 
Females have higher FOP7–9 and are more sensitive to pain and less sensitive to pain 
inhibition than males.1,5,10,11 Furthermore, the prevalence of several chronic pain condi-
tions is higher in females than in males.5 Thus, the association between FOP and pain 
and sex differences in FOP and pain are well established.
FOP is related to avoidant pain behaviors, for example, avoidance of situations that 
involve or may involve pain experience. It has been argued that FOP is more disabling 
than the actual pain.12 Testing the applicability of FOP questionnaire is, therefore, of 
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great importance. In order to accurately capture FOP, the 
FOP questionnaires should mirror FOP across sex and age. 
Furthermore, the validation of FOP questionnaires is crucial 
for the development of personalized medicine and treatments.
The Fear of Pain Questionnaire-III (FPQ-III) was devel-
oped by McNeil and Rainwater in 1998.13 Since then, it 
has been translated into several different languages, and 
has become widely used in both clinical6 and nonclinical 
samples.1 The FPQ-III consists of 30 items and three sub-
scales: fear of Severe Pain, Minor Pain and Medical Pain. 
Asmundson et al14 examined the factor structure, consistency 
and validity of the FPQ-III in a Canadian sample of 589 
undergraduates, and concluded that the model had unac-
ceptable fit. Similar findings have been made by others.8,14,15 
The Fear of Pain Questionnaire-Short Form (FPQ-SF) was, 
therefore, suggested as an alternative and better adjusted 
questionnaire for measurements of FOP.14 This questionnaire 
is reduced to 20 items and is divided into four subscales: fear 
of Severe Pain, Minor Pain, Injection Pain and Dental Pain.
It has been argued that the FPQ-SF enables factor struc-
ture invariance across sex, and thus is better suited for mea-
suring FOP in both males and females.14 The psychometric 
properties of the FPQ-III have been investigated previously, 
and sex differences were reported in FPQ-III Total and the 
three subscales: Severe Pain, Minor Pain and Medical Pain.8,9 
However, van Wijk and Hoogstraten developed a German 
version of the FPQ-III and found no sex differences in their 
sample. Thus, translational, linguistic and cultural issues 
may contribute to increase or decrease sex differences in 
endorsed FOP.16 Therefore, the main aim of this study was 
to investigate the FPQ-III’s and FPQ-SF’s model fit, reliabil-
ity and validity in a Norwegian sample, in order to explore 
the questionnaires’ applicability. The secondary aim was to 
investigate the models’ sex neutrality, that is, how well the 
questionnaires measure FOP across sex groups. We hypoth-
esized that the FPQ-SF would have a better model fit than the 
FPQ-III. We also expected sex differences in the model fit 
of the FPQ-III, but not the FPQ-SF. Higher fit was expected 
for women than for men in the FPQ-III model. Furthermore, 
higher FOP scores were expected in females than in males.
Methods
Participants
A total of 807 healthy participants were included in the study: 
339 males, age range 18–40 years, mean 23.4, standard 
deviation (SD)=4.1, and 468 females, age range 18–40 years, 
mean =22.1, SD=3.4. The participants were undergraduate 
students recruited on campus at the University of Tromsø and 
screened for medical history of serious diseases or injuries. 
Somatic or psychiatric disorders and use of prescription-based 
medications or allergy medications led to exclusion from 
participation. Pregnant women were excluded. Participants 
were instructed to abstain from use of nicotine- and caffeine-
containing substances 3 hours before participation. The 
participants had to speak Norwegian as Norwegian language 
was used in the questionnaires, instructions, consent and mea-
surements of pain, stress and activation collected in the experi-
ments. Data from seven different study samples were pooled. 
All participants filled in the FPQ-III and an informed consent 
form. The studies were approved by the Regional Committee 
for Medical Research Ethics North Norway (project numbers: 
2013/966, 2012/1888, 2610.00001, 49/2005, 5.2006.2452; 
20277, 17/2006).
Measures
The FPQ-III measures pain-related fear on a 30-item ques-
tionnaire. Each question presents a pain-related situation, and 
participants are asked to rate FOP on a 5-point Likert scale 
(1= not afraid at all, 5= extremely afraid). The FPQ-III is 
further divided into three factorial distinct subscales consist-
ing of 10 questions: Severe Pain (eg, being involved in a car 
accident), Minor Pain (eg, biting your tongue) and Medical 
Pain (eg, receiving an injection in your mouth). McNeil and 
Rainwater reported that the psychometric properties of the 
FPQ-III were considered satisfactory,7 with good internal 
consistency and test–retest reliability. Similar findings have 
been reported by others.16–18 A Norwegian version of the 
FPQ-III, translated by Lyby et al, was used in this study.4
The FPQ-SF is a reduced version of the FPQ-III. The 
FPQ-SF was developed by Asmundson et al,14 who reported 
good internal consistency and construct validity. This reduced 
version of the FPQ-III consists of 20 items and has four 
factorial distinct subscales: Severe, Minor, Injection (hav-
ing a blood sample drawn) and Dental Pain (having a tooth 
pulled). The questionnaire is organized in a similar format 
as the FPQ-III, with a 5-point Likert scale. To date, there is 
limited knowledge about the FPQ-SF’s reliability and validity.
Procedure
The participants were recruited from the University of 
Tromsø. All subjects were participants in pain studies and 
filled in the FPQ-III and a written consent form prior to test-
ing. Data obtained from the pain experiments are published 
elsewhere.1,4,10,19,20
Statistical analyses
Firstly, SPSS version 24 was used to run independent samples 
t-tests to examine whether there were sex differences on 
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subscale level. p values from the analysis of variance were 
corrected for multiple comparisons by the Holm– Bonferroni 
procedure. Secondly, IBM SPSS AMOS version 22 (IBM 
Corporation, Armonk, NY, USA), maximum likelihood 
estimation was used to conduct confirmatory factor analysis 
(CFA) in order to examine the fit of the two models to the 
data and the possible sex differences in model fit.21 The fit 
of the models to the data was evaluated by the c2/degrees of 
freedom ratio, the root mean square error of approximation 
(RMSEA), the goodness-of-fit index (GFI), the expected 
cross-validation index (ECVI) and the comparative fit 
index (CFI). Traditionally, a good fit model should have 
2:1 or 5:1 c2/degrees of freedom ratio, RMSEA <0.08 or 
0.10 (preferably <0.05), GFI >0.90, lower values of ECVI 
indicating a closer fit and CFI >0.90 (preferably >0.95).21–23 
Two multigroup CFAs (chi-square difference test) were used 
to examine if the measurement models differed across the 
two sex groups. Three (FPQ-III) and four (FPQ-SF) factors 
respectively were held constant simultaneously across the sex 
groups (i.e., configural invariance) and the factor loadings 
were constrained to be equal across the sex groups (i.e., a 
test if there are equal factor loadings or metric invariance) in 
the multigroup analysis. Lastly, IBM SPSS version 24 (IBM 
Corporation) was used to calculate Cronbach’s a values for 
the factors in the two models as well as to determine the 
intercorrelations between the sum scores of factors in the 
FPQ-III and the FPQ-SF. Acceptable high Cronbach’s a is 
0.7 and above.24
Results
Descriptive statistics
Descriptive statistics for FPQ-III and FPQ-SF total and 
subscale mean scores and standard deviations for males and 
females are presented in Table 1. Independent samples t-tests 
revealed that females scored significantly higher than males 
on all subscales of the FPQ-III: Severe Pain (t (1.805)=−8.60, 
p<0.001), Minor Pain (t (1.805)=3.49, p=0.001) and Medical 
Pain (t (1.805)=−4.25, p<0.001) and the Holm–Bonferroni 
adjusted a level=0.01. Furthermore, females scored sig-
nificantly higher than males on all subscales of the FPQ-
SF: Severe Pain (t (1.805)=−7.99, p<0.001), Minor Pain 
(t (1.805)=−3.93, p=0.001), Injection Pain (t (1.805)=4.00, 
p<0.001) and Dental Pain (t (1.805)=−3.15, p=0.002).
Fit indices
Fit indices for the two tested models are presented in Table 2. 
In line with the main hypothesis, the FPQ-SF had the best over-
all fit. The second hypothesis was not fully confirmed, as the 
results revealed that model fit differed across sex for both the 
FPQ-III and the FPQ-SF. The FPQ-III had a slightly better fit 
for males, and the FPQ-SF had a slightly better fit for females. 
Further analysis (multigroup CFA) showed that the differences 
in model fit across the sex groups were significant in the FPQ-
III model (p<0.000) and nonsignificant in the FPQ-III model 
(p=0.054) as hypothesized. Additionally, the FPQ-SF had a 
better overall fit, as indicated by the fit indices presented in 
Table 2. However, neither of the models showed very good fit, 
although the fit was adequate according to some of the prede-
termined criteria (RMSEA and ECVI). The factorial structures 
with standardized parameter estimates (factor loadings and 
squared multiple correlations) for the FPQ-III and FPQ-SF 
in the whole sample are presented schematically in Figures 1 
and 2. Standardized parameter estimates (factor loadings and 
squared multiple correlations) for men and women separately 
Table 1 Descriptive statistics of the FPQ-III and the FPQ-SF
Males  
(n=339)
Females  
(n=468)
Both  
(N=807)
Mean SD Mean SD Mean SD
FPQ-III 73.4 14.3 80.7 13.8 77.6 14.3
Severe pain 32.4 6.9 36.9 6.1 34.7 6.7
Minor pain 18.2 5.1 19.5 5.2 18.9 5.2
Medical pain 22.7 6.1 24.7 6.4 23.8 6.4
FPQ-SF 46.8 10.0 51.8 9.6 49.7 10.1
Severe pain 19.0 4.7 21.6 4.2 20.5 4.6
Minor pain 14.6 4.2 15.7 4.4 15.0 4.4
Injection pain 5.5 2.4 6.3 2.9 6.0 2.7
Abbreviations: FPQ-III, Fear of Pain Questionnaire-III; FPQ-SF, Fear of Pain 
Questionnaire-Short Form; SD, standard deviation.
Table 2 Fit indices of the FPQ-III and the FPQ-SF obtained by means of CFA
Model Factors Items c² (df) GFI CFI RMSEA CI ECVI CI
FPQ-III (N=807) 3 30 3107.65 (402) 0.78 0.70 0.091 0.088–0.094 4.01 3.796–4.237
Males (n=339) 3 30 1633.50 (402) 0.75 0.69 0.095 0.090–0.100 5.20 4.848–5.585
Females (n=468) 3 30 2189.88 (402) 0.72 0.65 0.098 0.094–0.102 4.95 4.653–5.281
FPQ-SF (N=807) 4 20 1251.46 (164) 0.85 0.82 0.091 0.086–0.095 1.66 1.532–1.811
Males (n=339) 4 20 697.72 (164) 0.82 0.80 0.098 0.091–0.106 2.33 2.106–2.589
Females (n=468) 4 20 752.46 (164) 0.85 0.83 0.088 0.082–0.094 1.82 1.646–2.012
Note: Criteria for a good fit are 2:1 or 5:1 c²/df, GFI >0.90, CFI >0.90, lower ECVI values indicate a closer fit and RMSEA <0.08 or 0.10 (preferably 0.05).
Abbreviations: CFA, confirmatory factor analysis; CFI, comparative fit index; CI, confidence interval; ECVI, expected cross-validation index; FPQ-III, Fear of Pain 
Questionnaire-III; FPQ-SF, Fear of Pain Questionnaire-Short Form; GFI, goodness-of-fit index; RMSEA, root mean square error of approximation.
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in the two models are presented in Table 3. The factor load-
ings presented in Figures 1 and 2 and Table 3 show the items 
correlation with the latent factor. As can be seen in Figures 
1 and 2 and Table 3, for the whole sample, none of the items 
loaded under the recommended cut-off of 0.3;25 however, some 
loaded below 0.5.26 In the female subgroup, items 18 and 27 
in the Severe FPQ-III subscale loaded below 0.3, and in male 
and female subgroups several items loaded below 0.5 in both 
models. None of the items in FPQ-III had loadings above 0.77, 
but in FPQ-SF several items loaded above 0.77.
Reliability and intercorrelations
The Cronbach’s a values showed high internal consistency for 
both the FPQ-III and the FPQ-SF (Tables 4 and 5). Accept-
able high Cronbach’s a is 0.7 and above. However, the values 
are affected by the number of items in each factor.24 Even 
though the FPQ-SF has fewer items than the FPQ-III, it still 
had acceptable a values. All intercorrelations between the 
factors were significant (Table 5). Positive and significant 
correlations were found between all the subscales.
Discussion
This study investigated the model fit, reliability, validity and 
sex neutrality of the FPQ-III and the FPQ-SF factor mod-
els. CFA revealed that none of the models had good fit, but 
the FPQ-SF provided a better overall fit than the FPQ-III. 
The ECVI, CFI and GFI favored the FPQ-SF, even though 
both CFI and GFI were below the recommended threshold. 
RMSEA was within the recommended threshold for both 
models; however, it was not within a good model fit range. 
The poor fit of the models is also mirrored in the standardized 
parameter estimates (factor loadings and squared multiple 
correlations), in which some items were below the recom-
mended factor loading threshold. There were sex differences 
in the model fit which were significant for the FPQ-III model, 
but not for the FPQ-SF, as hypothesized.
Figure 1 The factor loadings and squared multiple correlations of the FPQ-III.
Abbreviations: FPQ-III, Fear of Pain Questionnaire-III; FPQ-III M, FPQ-III Minor Pain; FPQ-III MP, FPQ-III Medical Pain; FPQ-III S, FPQ-III Severe Pain.
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Figure 2 The factor loadings and squared multiple correlations of the FPQ-SF.
Abbreviations: FPQ-SF, Fear of Pain Questionnaire Short Form; FPQ-SF MD, FPQ-SF Dental Pain; FPQ-SF I, FPQ-SF Injection Pain; FPQ-SF M, FPQ-SF Minor Pain; FPQ-SF 
S, FPQ-SF Severe Pain.
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6 (0.90) FPQ-SF S FPQ-SF M
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Table 3 The factor loadings and squared multiple correlations of the FPQ-III and the FPQ-SF among males and females separately
FPQ-III
F M F M F M F M F M F M F M F M F M F M
In 2 2 4 4 7 7 12 12 19 19 22 22 23 23 24 24 28 28 30 30
Mi fl 0.54 0.61 0.62 0.64 0.53 0.61 0.51 0.55 0.70 0.72 0.52 0.53 0.53 0.55 0.57 0.43 0.51 0.46 0.40 0.52
r 0.29 0.38 0.38 0.41 0.28 0.37 0.26 0.30 0.49 0.52 0.27 0.28 0.28 0.31 0.32 0.18 0.32 0.21 0.16 0.27
In 1 1 3 3 5 5 6 6 9 9 10 10 13 13 18 18 25 25 27 27
S fl 0.48 0.59 0.89 0.75 0.54 0.66 0.91 0.77 0.50 0.69 0.48 0.67 0.50 0.56 0.27 0.43 0.36 0.56 0.26 0.44
r 0.23 0.35 0.80 0.57 0.29 0.43 0.82 0.60 0.25 0.48 0.23 0.45 0.25 0.31 0.07 19 0.13 0.31 0.07 0.19
In 8 8 11 11 14 14 15 15 16 16 17 17 20 20 21 21 26 26 29 29
MP fl 0.71 0.65 0.82 0.72 0.76 0.71 0.41 0.50 0.32 0.33 0.72 0.75 0.52 0.59 0.44 0.48 0.42 0.58 0.36 0.52
r 0.50 42 0.67 0.51 0.57 0.51 0.17 0.25 0.10 0.11 0.52 0.57 0.27 0.35 0.20 0.23 0.17 0.34 0.13 0.27
Covariates F Mi-S 0.33 Mi-MP 0.47 S-MP 0.22
Covariates M Mi-S 0.47 Mi-MP 0.62 S-MP 0.30
FPQ-SF
In 2 2 4 4 7 7 19 19 22 22 23 23 24 24 28 28
Mi fl 0.55 0.67 0.67 0.72 0.51 0.58 0.75 0.74 0.50 0.50 0.50 0.38 0.48 0.41 0.42 0.53
r 0.30 0.45 0.45 0.51 0.26 0.34 0.56 0.55 0.25 0.25 0.25 0.29 0.29 0.14 0.23 0.17
In 1 1 3 3 5 5 6 6 9 9 10 10
S fl 0.44 0.52 0.92 0.86 0.50 0.57 0.93 0.87 0.46 0.63 0.44 0.59
r 0.19 0.27 0.85 0.74 0.25 0.32 0.86 0.75 0.22 0.40 0.19 0.35
In 8 8 11 11 14 14
I fl 0.62 0.77 0.92 0.86 0.54 0.69
r 0.79 0.59 0.96 0.75 0.74 0.48
In 17 17 26 26 29 29
D fl 0.82 0.76 0.52 0.68 0.52 0.60
r 0.62 0.59 0.92 0.47 0.54 0.36
Covariates F I-S 0.10 Mi-S 0.29 Mi-D 0.42 D-I 0.65 Mi-I 0.26 D-S 0.21
Abbreviations: D, dental; F, female; fl, factor loading; FPQ-III, Fear of Pain Questionnaire-III; FPQ-SF, Fear of Pain Questionnaire Short Form; I, injection; In, item number; 
M, men; Mi, minor; MP, medical pain; r, squared multiple correlations; S, severe.
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The internal consistency of the FPQ-III subscales was 
good (ranging from 0.82 to 0.85). The internal consistency 
of the FPQ-SF subscales was good for the Severe and Injec-
tion Pain subscales (0.84) and acceptable for the Minor and 
Medical Pain subscales (0.70 and 0.78). Thus, the findings 
from the FPQ-III are in line with previous studies.7,17 How-
ever, the finding of good internal consistency on all FPQ-SF 
subscales by Asmundson et al14 was not replicated in this 
study. Few studies have examined the FPQ-SF. In this study, 
the FPQ-III was administered to all participants. Future 
investigations should administer and examine the FPQ-SF, 
as other results may emerge when subjects respond to this 
shorter FOP questionnaire.
This study used a Norwegian version of the FPQ-III. 
Therefore, translation or linguistic issues may have influenced 
the results. The Norwegian version of the FPQ-III was devel-
oped by Lyby et al by translation and back-translation.4 It has 
been argued that back-translation is highly important in the 
translation process as it enables identification of translation 
or linguistic errors or imprecisions.27 However, retransla-
tion was not conducted in the translation process with the 
Norwegian version of the FPQ-III. Future studies could use 
translation, back-translation and retranslation to ensure an 
optimal final translation.
A probable explanation of the discrepancies between our 
findings and findings made in previous studies is that cultural 
issues influence FOP scoring. Social, cultural and psycho-
logic factors mediate pain behavior,28,29 and some cultures 
value expression of emotional and physiologic distress more 
than other cultures.30 Cultural variations have been found in 
the expression of pain31 and in the effectiveness of analgesic 
medications.32–34 Additionally, it has been demonstrated that 
there are cross-cultural sex differences in attitudes toward the 
expression of pain.35 One study reported that Indian research 
participants disapproved pain expression to a greater extent 
than American research participants. Moreover, the results 
revealed that participants from both countries considered pain 
expression by males less appropriate than pain expression by 
females. Hobara included a sample of Japanese and Euro-
American participants, and found that Japanese participants 
were less accepting of pain expression than Euro-American 
participants.30 Furthermore, participants from the Japanese 
culture disapproved male pain expression to a larger extent 
than participants from the Euro-American culture. Such 
cultural differences may also apply to sex differences in 
FOP observed in this and other studies, and may be related 
to differing gender role stereotypes or gender role expecta-
tions between cultures. The significant impact of gender role 
stereotypes is supported by several studies demonstrating 
that males report lower pain to female experimenters than to 
male experimenters.36–38 Thus, cultural factors combined with 
psychosocial factors may increase or decrease pain expres-
sion, but the relative contribution of cultural factors remains 
unknown. Previous studies employing the German and 
English versions of the FPQ-III have reported considerably 
lower mean subscale scores compared to the present study.7,16 
The mean subscale scores from our sample correspond to, 
for example, Roelofs et al,9 who used a Dutch version of the 
FPQ-III. Further investigations that include samples with dif-
ferent languages and/or samples from different cultures could 
help to clarify issues of linguistic and cultural differences. 
In summary, none of the FOP models seemed to capture 
FOP well, thus questioning the questionnaires’ applicability 
in Norway. In other words, these models do not capture the 
structural constructs of FOP well in Norway.
In line with our hypothesis, there were differences in 
model fit for males and females. The fit indices showed 
that FPQ-III had a slightly better fit for males than females, 
whereas the FPQ-SF had a slightly better fit for females than 
males. The multigroup CFA analysis confirmed the differ-
ences in the FPQ-III model, but not in the FPQ-III model. 
In the FPQ-SF, 10 items were removed from the original 
FPQ-III model. Elimination of some of the items where sex 
differences occur may contribute to sex neutrality. However, 
the analysis still revealed sex differences on the FPQ-SF 
subscales, albeit nonsignificant for the whole model. A recent 
study found that sex differences on the FPQ-III were mainly 
due to differences in male and female responses to items 
Table 4 Subscale intercorrelations (Pearson correlation) and 
internal consistency (Cronbach’s a) of the FPQ-III subscales 
(N=807)
Factors Severe 
Pain
Minor 
Pain
Medical 
Pain
Cronbach’s 
a
Severe Pain 0.854
Minor Pain 0.387** 0.821
Medical Pain 0.359** 0.537** 0.828
Notes: Acceptable Cronbach’s a <0.7. **p=0.001.
Abbreviation: FPQ-III, Fear of Pain Questionnaire-III.
Table 5 Subscale intercorrelations (Pearson correlation) and 
internal consistency (Cronbach’s a) of the FPQ-SF subscales 
(N=807)
Factors Severe 
Pain
Minor  
Pain
Injection 
Pain
Dental 
Pain
Cronbach’s 
a
Severe Pain 0.841
Minor Pain 0.352** 0.789
Injection Pain 0.132** 0.284** 0.843
Dental Pain 0.251** 0.370** 0.505** 0.706
Notes: Acceptable Cronbach’s a <0.7. **p<0.01.
Abbreviation: FPQ-SF, Fear of Pain Questionnaire-Short Form.
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comprising the Severe Pain subscale.39 In that study, it was 
concluded that sex differences observed on the FPQ-III may 
have been due to different emotional reactions to or different 
interpretations of Severe Pain items in males and females. In 
females, such items may have elicited, for example, anxiety, 
while in males the items may have elicited, for example, 
fear. Anxiety may represent fear or worry about incidents 
that might occur in the future, while fear may be understood 
as an immediate and temporary reaction. The findings from 
this study support this, as the largest sex differences were 
observed on the Severe subscale.
Asmundson et al argued that the FPQ-SF was better 
adjusted for sex, compared to the FPQ-III.14 Our results sup-
port this, as the FPQ-SF has better overall fit as well as better 
fit among both men and women. The multigroup analysis 
provides further support that the FPQ-SF is better adjusted 
for sex than the FPQ-III.
The sex differences in mean subscale FOP scores in 
our sample, displayed by the independent samples t-tests, 
revealed higher FOP in females than in males. Similar find-
ings have been made previously.1,7,17,30,39 In a study by McNeil 
and Rainwater, sex differences were found on overall, Severe, 
Medical and Minor Pain subscales.7 Osman et al reported 
that females scored significantly higher on FOP than males 
on two of three subscales.17 Lyby et al found significantly 
higher overall FOP scores in females than males.1 Thus, there 
are some inconsistencies in the existing literature regarding 
where the sex differences in FOP appear, with some studies 
reporting sex differences on overall FOP and others at one 
or several of the subscales. However, the direction of the sex 
difference in FOP is consistent, with higher FOP in females 
than in males.
Sex differences in FOP scores measured by the FPQ-III 
have been observed in several different translated versions, 
including the Norwegian, English, Dutch and French versions 
of the FPQ-III.1,7–9,30,40 However, absence of sex differences 
has also been observed, for example, in the responses to the 
German FPQ-III version by Van Wijk et al.16 The larger sex 
differences in FOP in some languages compared to others 
may thus be explained by translational or linguistic issues.
Further investigations could examine possible contrib-
uting factors for the observed sex differences in FOP by 
evaluating psychologic, physiologic, linguistic and/or cul-
tural mechanisms. Refining the FPQ-III model may help on 
the proposed lack of sex neutrality, and thus develop it as a 
more reliable tool for measurement of FOP in both males 
and females.
Limitations
The present study has several limitations. First, all par-
ticipants responded to the FPQ-III. Therefore, it is possible 
that other results would emerge if the FPQ-SF had been 
distributed. Future investigations should, therefore, include 
samples where the FPQ-SF, and not only the FPQ-III, is 
applied. Second, only nonclinical samples were included in 
this study, so the findings may not be generalizable to clini-
cal samples. Third, the sample consisted of undergraduate 
students at the University of Tromsø, thus contributing to 
sample homogeneity of age and education. The discrepancy 
in findings in this and other studies may, therefore, be due 
to inclusion of participants of different age or educational 
statuses. Fourth, a Norwegian translation of the FPQ-III was 
used. Thus, the findings may not be directly transferable to 
FPQ measures in other languages and/or cultures.
Conclusion
The present study shows that none of the FOP models capture 
FOP well in this Norwegian nonclinical sample. However, the 
FPQ-SF is a better model than the FPQ-III. Additionally, sex 
differences were found in the two models fit. The FPQ-SF 
is a slightly better measurement theory of FOP for females, 
whereas the FPQ-III is slightly better for males. When testing 
if the models significantly differed in model fit across sex, the 
FPQ-SF was not significantly different, but the FPQ-III was. 
As none of the models proves good fit, adjustment of the FPQ 
to increase usefulness and ensure accurate FOP measures in 
Norwegian samples is highly recommended.
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